August 16, 2023 Comments Off on New patent for Pfizer drug IBRANCE Posted in: Patent Added Annual Drug Patent Expirations for IBRANCE Ibrance is a drug marketed by Pfizer and is included in two NDAs. It is available from two suppliers. There are six patents protecting…
The post New patent for Pfizer drug IBRANCE appeared first on DrugPatentW…
August 16, 2023 Comments Off on New patent for Abbvie drug RINVOQ Posted in: Patent Added Annual Drug Patent Expirations for RINVOQ Rinvoq is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are twenty-four patents protecting…
The post New patent for Abbvie drug RINVOQ appeared first on DrugPate…
